Risk factors for selection of the L74I reverse transcriptase mutation in HIV-1 infected patients

被引：0
|
作者：
Marcelin, A. G.
Wirden, M.
Roquebert, B.
Derache, A.
Simon, A.
Ghosn, J.
Dominguez, S.
Katlama, C.
Calvez, V.
机构：
[1] Hop La Pitie Salpetriere, Dept Virol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Internal Med, Paris, France
[3] Univ Paris 06, Paris, France
来源：
ANTIVIRAL THERAPY | 2006年 / 11卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [31] Reverse transcriptase mutation M184V delays the selection of thymidine-analogue mutations in children infected with subtype-C HIV-1
    Averbuch, D
    Schapiro, JM
    Engelhard, D
    Gradstein, S
    Gottesman, G
    Kedem, E
    Einhorn, M
    Grisaru-Soen, G
    Ofir, M
    Milguir, F
    Rudich, H
    Ram, D
    Grossman, Z
    ANTIVIRAL THERAPY, 2004, 9 (04) : U114 - U115
  • [32] The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients
    Di Biagio, Antonio
    Ricci, Elena
    Viscoli, Claudio
    Mesini, Alessio
    Menzaghi, Barbara
    Carenzi, Laura
    Orofino, Giancarlo
    Parruti, Giustino
    Martinelli, Canio
    Madeddu, Giordano
    De Socio, Giuseppe V.
    Franzetti, Marco
    Quirino, Tiziana
    Bonfanti, Paolo
    CURRENT HIV RESEARCH, 2013, 11 (03) : 179 - 186
  • [33] Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: The smart study.
    Gianotti, N
    Setti, M
    Manconi, PE
    Leoncini, F
    Chiodo, F
    Minoli, L
    Moroni, M
    Angarano, G
    Mazzotta, F
    Carosi, G
    Antonelli, G
    Lazzarin, A
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2002, 15 (02) : 129 - 139
  • [34] Polymorphism and drug selected mutations of reverse transcriptase gene in 102 HIV-1 infected patients living in China
    Liu, Li
    Lu, Hong Zhou
    Henry, Mireille
    Tamalet, Catherine
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) : 1593 - 1599
  • [35] Variable Selection Based QSAR Modeling on Bisphenylbenzimidazole as Inhibitor of HIV-1 Reverse Transcriptase
    Kumar, Surendra
    Tiwari, Meena
    MEDICINAL CHEMISTRY, 2013, 9 (07) : 955 - 967
  • [36] The V118I mutation in the reverse transcriptase of HIV-1 diminishes the incorporation of multiple nucleoside analogue inhibitors
    Girouard, M
    Diallo, K
    Marchand, B
    McCormick, S
    Wainberg, MA
    Götte, M
    ANTIVIRAL THERAPY, 2002, 7 : S31 - S31
  • [37] Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase
    Mosing, RK
    Mendonsa, SD
    Bowser, MT
    ANALYTICAL CHEMISTRY, 2005, 77 (19) : 6107 - 6112
  • [38] Mechanism of Resistance to GS-9148 Conferred by the Q151L Mutation in HIV-1 Reverse Transcriptase
    Scarth, Brian J.
    White, Kirsten L.
    Chen, James M.
    Lansdon, Eric B.
    Swaminathan, S.
    Miller, Michael D.
    Goette, Matthias
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2662 - 2669
  • [39] Selection and Characterization of HIV-1 with a Novel S68 Deletion in Reverse Transcriptase
    Schinazi, Raymond F.
    Massud, Ivana
    Rapp, Kimberly L.
    Cristiano, Meta
    Detorio, Mervi A.
    Stanton, Richard A.
    Bennett, Matthew A.
    Kierlin-Duncan, Monique
    Lennerstrand, Johan
    Nettles, James H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2054 - 2060
  • [40] Incidence of and risk factors for hepatotoxicity associated with nevirapine in HIV-1 infected patients
    Launay, O
    Boukli, N
    Tréluyer, JM
    Roudiere, L
    Rey, E
    Urbinelli, R
    Allaert, FA
    Caumes, E
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S121 - S121
12345